297 related articles for article (PubMed ID: 18000882)
1. Mass spectrometric determination of insulins and their degradation products in sports drug testing.
Thevis M; Thomas A; Schänzer W
Mass Spectrom Rev; 2008; 27(1):35-50. PubMed ID: 18000882
[TBL] [Abstract][Full Text] [Related]
2. Mass spectrometry in sports drug testing: Structure characterization and analytical assays.
Thevis M; Schänzer W
Mass Spectrom Rev; 2007; 26(1):79-107. PubMed ID: 16888758
[TBL] [Abstract][Full Text] [Related]
3. Insulins in equine urine: qualitative analysis by immunoaffinity purification and liquid chromatography/tandem mass spectrometry for doping control purposes in horse-racing.
Kuuranne T; Thomas A; Leinonen A; Delahaut P; Bosseloir A; Schänzer W; Thevis M
Rapid Commun Mass Spectrom; 2008; 22(3):355-62. PubMed ID: 18181226
[TBL] [Abstract][Full Text] [Related]
4. Doping control analysis of intact rapid-acting insulin analogues in human urine by liquid chromatography-tandem mass spectrometry.
Thevis M; Thomas A; Delahaut P; Bosseloir A; Schänzer W
Anal Chem; 2006 Mar; 78(6):1897-903. PubMed ID: 16536426
[TBL] [Abstract][Full Text] [Related]
5. New drugs and methods of doping and manipulation.
Thevis M; Kohler M; Schänzer W
Drug Discov Today; 2008 Jan; 13(1-2):59-66. PubMed ID: 18190865
[TBL] [Abstract][Full Text] [Related]
6. Quantification of human insulin-like growth factor-1 and qualitative detection of its analogues in plasma using liquid chromatography/electrospray ionisation tandem mass spectrometry.
Bredehöft M; Schänzer W; Thevis M
Rapid Commun Mass Spectrom; 2008; 22(4):477-85. PubMed ID: 18236437
[TBL] [Abstract][Full Text] [Related]
7. Mass spectrometric identification of peptide hormones in doping-control analysis.
Thevis M; Schänzer W
Analyst; 2007 Apr; 132(4):287-91. PubMed ID: 17554406
[TBL] [Abstract][Full Text] [Related]
8. Mass spectrometric identification of degradation products of insulin and its long-acting analogues in human urine for doping control purposes.
Thomas A; Thevis M; Delahaut P; Bosseloir A; Schänzer W
Anal Chem; 2007 Mar; 79(6):2518-24. PubMed ID: 17300174
[TBL] [Abstract][Full Text] [Related]
9. Mass spectrometric identification and characterization of a new long-term metabolite of metandienone in human urine.
Schänzer W; Geyer H; Fusshöller G; Halatcheva N; Kohler M; Parr MK; Guddat S; Thomas A; Thevis M
Rapid Commun Mass Spectrom; 2006; 20(15):2252-8. PubMed ID: 16804957
[TBL] [Abstract][Full Text] [Related]
10. Determination of therapeutics with growth-hormone secretagogue activity in human urine for doping control purposes.
Thevis M; Wilkens F; Geyer H; Schänzer W
Rapid Commun Mass Spectrom; 2006; 20(22):3393-402. PubMed ID: 17051614
[TBL] [Abstract][Full Text] [Related]
11. Recommended criteria for the mass spectrometric identification of target peptides and proteins (<8 kDa) in sports drug testing.
Thevis M; Loo JA; Loo RR; Schänzer W
Rapid Commun Mass Spectrom; 2007; 21(3):297-304. PubMed ID: 17200979
[TBL] [Abstract][Full Text] [Related]
12. Screening for 2-quinolinone-derived selective androgen receptor agonists in doping control analysis.
Thevis M; Kohler M; Maurer J; Schlörer N; Kamber M; Schänzer W
Rapid Commun Mass Spectrom; 2007; 21(21):3477-86. PubMed ID: 17985352
[TBL] [Abstract][Full Text] [Related]
13. Insulin.
Thevis M; Thomas A; Schänzer W
Handb Exp Pharmacol; 2010; (195):209-26. PubMed ID: 20020367
[TBL] [Abstract][Full Text] [Related]
14. Doping control analysis of selected peptide hormones using LC-MS(/MS).
Thevis M; Thomas A; Schänzer W
Forensic Sci Int; 2011 Dec; 213(1-3):35-41. PubMed ID: 21752560
[TBL] [Abstract][Full Text] [Related]
15. Proteases in doping control analysis.
Thevis M; Maurer J; Kohler M; Geyer H; Schänzer W
Int J Sports Med; 2007 Jul; 28(7):545-9. PubMed ID: 17525883
[TBL] [Abstract][Full Text] [Related]
16. Qualitative determination of synthetic analogues of insulin in human plasma by immunoaffinity purification and liquid chromatography-tandem mass spectrometry for doping control purposes.
Thevis M; Thomas A; Delahaut P; Bosseloir A; Schänzer W
Anal Chem; 2005 Jun; 77(11):3579-85. PubMed ID: 15924392
[TBL] [Abstract][Full Text] [Related]
17. Doping control analysis of tricyclic tetrahydroquinoline-derived selective androgen receptor modulators using liquid chromatography/electrospray ionization tandem mass spectrometry.
Thevis M; Kohler M; Thomas A; Schlörer N; Schänzer W
Rapid Commun Mass Spectrom; 2008 Aug; 22(16):2471-8. PubMed ID: 18634123
[TBL] [Abstract][Full Text] [Related]
18. 6alpha-Methylandrostenedione: gas chromatographic mass spectrometric detection in doping control.
Parr MK; Kazlauskas R; Schlörer N; Opfermann G; Piper T; Schulze G; Schänzer W
Rapid Commun Mass Spectrom; 2008; 22(3):321-9. PubMed ID: 18181236
[TBL] [Abstract][Full Text] [Related]
19. Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator andarine (S-4) for routine doping control purposes.
Thevis M; Thomas A; Fusshöller G; Beuck S; Geyer H; Schänzer W
Rapid Commun Mass Spectrom; 2010 Aug; 24(15):2245-54. PubMed ID: 20623476
[TBL] [Abstract][Full Text] [Related]
20. Mass spectrometric determination of gonadotrophin-releasing hormone (GnRH) in human urine for doping control purposes by means of LC-ESI-MS/MS.
Thomas A; Geyer H; Kamber M; Schänzer W; Thevis M
J Mass Spectrom; 2008 Jul; 43(7):908-15. PubMed ID: 18563864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
